There is the added problem that we will shortly be assuming the EU Presidency, under which it will be our job to try to bring people together. There is – I accept that this would be irrelevant if one took the strong moral view expressed by many of my colleagues – the question of pharmaceutical biotechnology research and whether we are completely consistent in how we approach it.